Epic Research Update : Suven Life Sciences

Suven Life Sciences (Suven) has secured two product patents for New Chemical Entities (NCEs) in Hong Kong and Canada for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid through 2023 and 2029 respectively.

For more information ✆ - 0731-6642300 or Visit https://www.epicresearch.co/